Exchange: NYSE·Updated 07:30 PM EDT
WST logo

WSTWest Pharmaceutical Services, Inc.

$365.01
$6.00
(1.67%)
Today
Closed $365.00
$0.01
(0.00%)
After Hours
EarningsJul 23
Mkt Cap$25.36B
Vol853,637.00
News
all
press releases
West Completes Sale and Transfer of the Manufacturing and Supply Rights for SmartDose 3.5mL On-Body Delivery System
West Completes Sale and Transfer of the Manufacturing and Supply Rights for SmartDose 3.5mL On-Body Delivery System West Completes Sale and Transfer of the Manufacturing and Supply Rights for SmartDose 3.5mL On-Body Delivery System PR Newswire EXTON, Pa., July 1, 2026 EXTON, Pa., July 1, 2026...
PR Newswire
News Placeholder
More News
News Placeholder
NovoCure's Cancer Treatment Device Option Pax Gets European Approval
NVCR secures European approval for Optune Pax, expanding access to its pancreatic cancer treatment after strong late-stage trial results.
Zacks
News Placeholder
MMSI or WST: Which Is the Better Value Stock Right Now?
MMSI vs. WST: Which Stock Is the Better Value Option?
Zacks
News Placeholder
NTRA & Aveta Partner to Advance MRD-Guided Trial in Head & Neck Cancer
Natera's Aveta partnership brings Signatera into a global Phase 3 head and neck cancer trial to assess MRD and treatment response.
Zacks
News Placeholder
Artivion Secures FDA Approval for AMDS Hybrid Prosthesis Device
AORT's FDA approval for AMDS removes a key hospital adoption hurdle and opens access to an estimated $150 million annual U.S. market.
Zacks
News Placeholder
Reasons to Retain TransMedics Stock in Your Portfolio for Now
TMDX is advancing its OCS platform and transplant ecosystem, but margin pressure from expansion investments remains a key concern.
Zacks
News Placeholder
Here's Why You Should Add BrightSpring Stock to Your Portfolio Now
BTSG's specialty, infusion and provider services momentum support growth, but IRA pressures and integration risks may weigh on margins.
Zacks
News Placeholder
GEHC Launches Allia Upgrade Pathways for Interventional Suites
GE HealthCare's Allia upgrade pathways let providers modernize legacy imaging systems with AI-enabled workflows while reducing construction and disruption.
Zacks
News Placeholder
Veeva Acquires Copli & Launches Falcon MLR for Faster Content Reviews
VEEV expands its AI push with Copli acquisition and Falcon MLR launch, aiming to speed life sciences content reviews and boost Commercial Cloud.
Zacks
News Placeholder
RDNT's Unit DeepHealth Expands AI Breast Suite With FDA-Cleared Tools
RadNet's DeepHealth gains FDA clearances for AI breast imaging tools that assess cardiovascular risk and compare prior mammograms.
Zacks
<
1
2
...
>

Advertisement|Remove ads.